REVEAL GENOMICS and Ona Therapeutics Join Forces to Advance Next-generation Cancer Treatment
BARCELONA, Spain--(BUSINESS WIRE)--Apr 14, 2025--
REVEAL GENOMICS and Ona Therapeutics today announced a strategic collaboration aimed at accelerating the clinical development of ONA-255, a next-generation ADC designed to enhance the precision and efficacy of cancer treatment across multiple tumor types.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250414211014/en/
ONA-255 is positioned to be a first-in-class molecule against a novel ADC target present in multiple, prevalent solid tumor types. Ona has privileged insight of the target as a hallmark of molecular adaptation in advanced diseases and its unique function as a universal driver of resistance to various therapies. ONA-255 is an ADC tailor-made to match the design of the molecule to the extraordinary biology of the target to deliver exceptionally potent drug against recalcitrant tumors, especially resistant clones for deeper and more durable responses.
At the heart of this collaboration is Dr. Aleix Prat, Co-Founder and Chief Scientific Officer of REVEAL GENOMICS. A globally recognized expert in precision oncology and drug development, Dr. Prat played a key role in identifying the ONA-255 drug target and generating, in collaboration with Ona Therapeutics and Dr. Roger Gomis, the critical preclinical data necessary for its clinical advancement. He also serves as the head of Ona Therapeutics' advisory board.
As a leader in genomic innovation, REVEAL GENOMICS will conduct a comprehensive molecular analysis of tumor and blood samples from the ONA-255 phase 1-2 clinical trial as part of this strategic collaboration. Leveraging proprietary technologies and advanced computational algorithms, the company will decode key molecular and genomic biomarkers to reveal insights into tumor biology, the immune microenvironment, and response mechanisms to ONA-255. This pioneering work will help define patient populations, identify predictive biomarkers, and deepen the understanding of ONA-255's mechanism of action—accelerating its clinical development and opening new therapeutic avenues.
To advance this partnership, Ona Therapeutics—working in collaboration with the U.S. subsidiary of REVEAL GENOMICS—has been awarded a grant from CDTI ( Centro para el Desarrollo Tecnológico y la Innovación ), a public entity under the Spanish Ministry of Science, Innovation, and Universities that promotes technological innovation and development. The grant is funded by the Plan de Recuperación, Transformación y Resiliencia – Funded by the European Union NextGenerationEU.
Valerie Vanhooren, Co-Founder and CEO of Ona Therapeutics, added, " ADCs have transformed cancer treatment; however, the technology has been applied to a limited number of tumor targets. These limitations restrict the number of patients who can benefit from treatments and highlight the critical need to identify new broadly expressed tumor targets. Ona's tailor-designed ADCs have the potential to define new treatment paradigms and patient populations, resulting in a clear benefit for patients with cancer. This partnership with REVEAL GENOMICS combines Ona's ADC experience with cutting-edge diagnosticswith the goal to transform the treatment landscape for aggressive solid tumors.'
Patricia Villagrasa, Co-Founder and CEO of REVEAL GENOMICS, stated, " Ona Therapeutics is at the forefront of developing next-generation cancer therapies. This collaboration marks a key milestone in combining advanced diagnostics with innovative treatments, reinforcing the strategic value of integrating biomarker science early in drug development. It also underscores REVEAL GENOMICS's leadership in driving biomarker strategy and our commitment to shaping new business models that bring precision oncology closer to patients.'
Dr. Aleix Prat commented, "
For further information visit: http://www.reveal-genomics.com
For further information visit: https://ona-therapeutics.com/
View source version on businesswire.com:https://www.businesswire.com/news/home/20250414211014/en/
Further information: Adriana Herrera,[email protected]
KEYWORD: EUROPE SPAIN UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: SCIENCE OTHER SCIENCE BIOTECHNOLOGY RESEARCH ONCOLOGY HEALTH CLINICAL TRIALS OTHER HEALTH
SOURCE: REVEAL GENOMICS
Copyright Business Wire 2025.
PUB: 04/14/2025 08:05 AM/DISC: 04/14/2025 08:06 AM
http://www.businesswire.com/news/home/20250414211014/en
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 days ago
- Yahoo
Trump says US doesn't have to meet NATO spending goal
President Donald Trump said Friday that the U.S. shouldn't have to abide by the same defense spending standards as the rest of NATO — potentially antagonizing leaders from the rest of the alliance days before he's to meet with them in The Netherlands. Trump has long demanded that NATO states spend 5 percent of their GDP on defense but has never said if the U.S. should be included in that or not. The U.S. is currently at 3.4 percent. "I don't think we should, but I think they should," he said, responding to a question about his 5 percent defense spending goal. "We've been supporting NATO so long. … So I don't think we should, but I think that the NATO countries should, absolutely," he added. The summit kicks off Tuesday in The Hague with the leaders of 32 member states coming together to plan spending goals and reaffirm NATO force structure and deployment plans. Most NATO states spend just over 2 percent of their GDP on defense currently, with a growing number having outlined plans to get to around 3 percent over the next year or two. Trump's spending demand has hovered over the alliance since his reelection however, and the alliance has come up with a novel solution: Call for 3.5 percent on defense, with the remaining 1.5 percent taken up by domestic infrastructure and cybersecurity spending. Trump's apparent opting out of the higher target is unlikely to sit well with Republicans on Capitol Hill who've pushed for larger Pentagon budgets and have clashed with the administration over defense spending. Both Sen. Roger Wicker (R-Miss.) and Rep. Mike Rogers (R-Ala.), the chairs of the Senate and House Armed Services Committees respectively, have been pushing to drive U.S. defense spending to 5 percent of GDP. They and other GOP leaders criticized Trump's budget plans for keeping annual defense funding flat, save a one-time investment from Republicans' megabill of spending and tax cuts. Hitting that goal would mean a roughly $1.4 trillion defense budget for the Pentagon. Only Poland, Estonia, Latvia and Lithuania have committed to 5 percent number so far, but most of the rest of the alliance is expected to follow suit at The Hague. There are outlines, however. The Spanish government, which is one of the lowest spenders on defense in the alliance, flatly rejected the 5 percent goal this week. In a letter to NATO Secretary General Mark Rutte obtained by POLITICO, Spanish Prime Minister Pedro Sánchez said his government 'cannot commit to a specific spending target in terms of GDP at this summit." Other allies who have spent more on defense in recent years are also grappling with how to keep pumping more money into their militaries. 'We have to find a realistic compromise between what is necessary and what is possible, really, to spend,' Germany's defense minister, Boris Pistorius said this month during a NATO meeting in Brussels. Seth Jones, president of the defense and security program at the Center for Strategic and International Studies, said in a press call Friday that U.S. defense spending, at 3.4 percent of GDP, is 'lower than during any time during the Cold War,' and the Trump administration's defense budget as a percentage of GDP 'is likely to be lower than the Carter administration's defense budget in the 1970s.' Connor O'Brien contributed to this report.
Yahoo
2 days ago
- Yahoo
Vera C. Rubin debut images: How to see the groundbreaking space photos from the world's largest camera
When you buy through links on our articles, Future and its syndication partners may earn a commission. The new Vera C. Rubin Observatory is set to release its debut images — taken with the largest digital camera ever built — on Monday (Jun. 23). The world-first images and videos will be ultra-high-definition and will show off the observatory's highly anticipated, cutting-edge capabilities for the first time. Here's what you need to know. If you want to watch from home, a news conference will be streaming on YouTube in English and Spanish at 11:00 a.m. EDT on Monday. The link to watch is posted on the observatory's website, and is also embedded here. If you'd prefer to bask in the awe of the cosmos with friends, you may be able to attend a watch party near you — or even host one of your own. Groups will gather across the globe in planetariums and universities to admire the highly detailed images and videos as they are released. The observatory has shared links to a map of all registered watch parties, as well as a link to sign up to become a host. During the news conference, the observatory team will introduce the Rubin Observatory before showcasing the new images and discussing their significance. Watch parties may also hear from local scientists and special guests. Be sure to check out the details of a watch party before you attend to learn about any extra programming. The observatory, perched high on a mountain in the Chilean Andes, will peer at interstellar comets and dangerous asteroids, as well as larger objects, like twisting galaxies and exploding supernovas. Related: 'People thought this couldn't be done': Scientists observe light of 'cosmic dawn' with a telescope on Earth for the first time ever Inside Rubin lies the world's largest digital camera and six of the largest optical filters ever produced. Together, they allow researchers to observe different facets of the universe in many wavelengths of light and remarkably high detail. The camera will take a new high-resolution photo of the sky around every 40 seconds. The images will then be transmitted via fiber optic cables to a supercomputer in California, which will analyze the photos. When stitched together, the images can act as a time-lapse video of space, one that is planned to span 10 years. RELATED STORIES —Space photo of the week: Observatory, or alien planet? Boggle your mind with this 360-degree image —Vera C. Rubin Observatory: The groundbreaking mission to make a 10-year, time-lapse movie of the universe —3,200-megapixel camera of the future Vera Rubin Observatory snaps record-breaking 1st photos Using its groundbreaking instruments, the observatory is expected to contribute to current understanding of widely debated phenomena, including dark energy and dark matter — two components that are thought to make up a vast majority of the universe, but remain poorly understood. The new images could be the first of many that vastly improve our understanding of the cosmos. Whether you join a watch party or tune in from the comfort of your couch, these photos are not to be missed.
Newsweek
2 days ago
- Newsweek
Exclusive: We Thought Having a Baby Was 'Impossible.' Then Doctors Used AI
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. The parents of the world's first baby born thanks to AI exclusively told Newsweek how a new IVF procedure powered entirely by artificial intelligence made the "impossible" a reality. The couple's hopes of starting a family were crushed when Edna, 42, and Tony, 45, were diagnosed with infertility issues, including Edna's ovarian insufficiency. But in 2023, they were introduced to a prototype study led by Conceivable Life Sciences through Hope IVF—a private clinic in Mexico City. From left to right: Luis, Dr Luis Miguel Campos (the patients' clinician), parents Edna and Tony. From left to right: Luis, Dr Luis Miguel Campos (the patients' clinician), parents Edna and Tony. Conceivable The precision of AI This study proved it was possible to control robotics within the IVF lab to perform ICSI, otherwise known as Intracytoplasmic Sperm Injection, remotely to create an embryo. This means embryos created through the robotic ICSI step receive consistent treatment with high precision and a more controlled approach to combining the egg and sperm, compared to current manual methods. The surgeon still oversees the robot and the processes, but with much improved outcomes. Edna and Tony—who are using their middle names for privacy—spoke exclusively to Newsweek about how they became the first family shaped by AI. "We represent expectations and hope for all those couples who are unable to reach their goal to become parents," they said through Spanish translation. "Once we heard the baby's heartbeat, we felt like we reached something that seemed previously impossible." A scalable model for fertility treatment The prototype study involved 41 patients and to date, has resulted in 21 pregnancies and 18 live births. Its system sees AI-powered robots help human doctors in a first step towards automating IVF treatments. The remote ICSI procedure used allows for a much gentler approach to embryo creation, helping improve quality outcomes at a microscopic level. Baby Luis (his real name) was born in Morelia in November 2024. Now seven-months-old, he has become the first baby to be conceived thanks to AI. Inside the AI system Chief medical officer at Conceivable Life Sciences, Dr. Alejandro Chavez-Badiola and one of the principal investigators on the paper, shared two scenarios: "Am I the lucky patient who is going to be treated by the best embryologist in the world at 8 a.m. after a cup of coffee and with a smile on their face, fully focused," he told Newsweek. "Or am I going to be the unlucky patient who is going to be treated by the best embryologist in the world at 1 p.m. when they're about to inject their 17th egg, thinking about lunch and having just received a distressing phone call from their partner." With this new system, the entire procedure uses mathematical algorithms and robotics to carry out the fertilization process step-by-step, with future precision likely to be beyond human capability. "Automation is not only allowing us to standardize these issues with the precision of robots, but to scale this [and] to make sure that every patient anywhere in the world, at any given time, can be treated by the best embryologists," Dr. Chavez-Badiola said. Remote ICSI photography. Remote ICSI photography. Conceivable Tony told Newsweek that the couple didn't have concerns about using the technology to finally become parents. "Although it can be directed to other purposes like weapons or other negative aspects, I feel like it should be applied on a daily basis, because well done, its purpose will be at the service of mankind," he said. While there will always be a clinical team overseeing the automated lab, remote control enables global teams to manage automated labs beyond regular hours, allowing for 18–20-hour workdays. Additionally, as the system can be operated remotely, a specialist in one country can carry out fertilization procedures for patients in another. Cost and duration were also differing factors from traditional methods, but the couple put their trust in the team at Conceivable. "By being more optimal and efficient, I feel like it will reduce the amount of attempts and the necessity of medications," Edna told Newsweek. Edna said that the process was fraught with emotion, given the negative outcomes of their previous IVF rounds. Edna was working in another city when she took the pregnancy test. "When I told Tony the news I was pregnant, it was a delightful surprise for him," she told Newsweek. "We were very happy." Luis, the first baby born from remote ICSI. Luis, the first baby born from remote ICSI. Conceivable The success rate of 51 percent aligns with industry standards, according to the Vienna Consensus. However, in their trials, the researchers also found that embryos created using this AI system had an as good—if not better—development potential than those made by humans alone, resulting in high-quality blastocysts—the stage at which embryos are typically relocated from an embryo transfer catheter to the uterus. Edna and Tony's clinician Dr. Luis Miguel Campos told Newsweek that once he had explained the process of ICSI to them, they saw it as an opportunity. "I joined this program to help two beautiful humans achieve their when they heard they were pregnant, I cried like never before," he said. As for next steps at Conceivable, Dr. Campos said consistency in outcomes is a top priority, eventually leading to an improvement in access for any patient around the world. "By [producing] consistency in results, the control process will imply reducing costs and be more efficient," he said. Ethics and AI Dr. Alexander Kotlyar, a reproductive endocrinologist and infertility specialist at Genesis Fertility, told Newsweek emerging AI tools in fertility can enhance core ethical principles, provided they are carefully assessed and properly trained. "The ethical debate around AI reminds me of the long-standing tug-of-war behind genetic testing of embryos," he said. "In both cases, there is concern about how the use of new technology, like DNA testing techniques, can truly benefit patient outcomes, [for example], getting pregnant and having a live birth." Dr. Kotlyar explained the use of AI in the fertility field has grown significantly since the first "test tube" baby was born over forty years ago. This development can be partly attributed to the fact that the processes behind AI algorithms are often not transparent, which raises questions about their outcomes and reliability. "This concern is even more profound with AI since decision-making is, at least partly, given to a machine," he told Newsweek. "However, I would reassure patients and the public that in both cases, the technology is always tested against the principles of core medical ethics and if we cannot stay true to those principles, then we do not use the technology." Hope for future parents For Edna and Tony, being the first successful participants of the prototype clinical trial is a dream come true. "We were fortunate to be selected over other candidates for this first treatment, and we feel blessed," they told Newsweek. "We encourage all those couples who are on the journey to becoming parents to not abandon their dreams and hopes." The couple received strong support from both sides of their families. "Some of them felt a little concerned but in the end, everyone was really happy for our outcome," Tony said. When he's old enough, both Edna and Tony will happily tell Luis that he was conceived using AI. "There's a lot of ignorance and certain concerns about technology, but we will explain gladly to our son." Do you have a tip on a health story that Newsweek should be covering? Do you have a question about IVF? Let us know via health@ Reference Mendizabal-Ruiz, G., Chavez-Badiola, A., Hernández-Morales, E., Valencia-Murillo, R., Ocegueda-Hernández, V., Costa-Borges, N., Mestres, E., Acacio, M., Matia-Algué, Q., Farías, A. F.-S., Carreon, D. S. M., Barragan, C., Silvestri, G., Martinez-Alvarado, A., Olmedo, L. M. C., Aguilar, A. V., Sánchez-González, D. J., Murray, A., Alikani, M., & Cohen, J. (2025). A digitally controlled, remotely operated ICSI system: Case report of the first live birth. Reproductive BioMedicine Online, 50(5).
